Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats

European Neuropsychopharmacology

Volumn 26, Issue 2, 2016, Pages 288-297

  Hutsell, Blake A ^a   Baumann, Michael H ^b   Partilla, John S ^b   Banks, Matthew L ^a   Vekariya, Rakesh ^a   Glennon, Richard A ^a   Negus, S Stevens ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

4 Methylcathinone; Cathinone; Drug abuse; Intracranial self stimulation; Rat; Stereoselectivity

Indexed keywords

4 METHYLCATHINONE; CATHINONE; DOPAMINE; DOPAMINE TRANSPORTER; MONOAMINE; NORADRENALIN; NORADRENALIN TRANSPORTER; SEROTONIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; 4-METHYLCATHINONE; ALKALOID; CENTRAL STIMULANT AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DRUG ABUSE; ELECTRICAL BRAIN STIMULATION TEST; ENANTIOMER; FACILITATION; IN VITRO STUDY; IN VIVO STUDY; INTRACRANIAL SELF-STIMULATION TEST; MALE; MONOAMINE RELEASE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY; STEREOISOMERISM; ANALYSIS OF VARIANCE; ANIMAL; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG DEPENDENCE; METABOLISM; PATHOPHYSIOLOGY; SELF STIMULATION; SPRAGUE DAWLEY RAT;

ALKALOIDS; ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; IN VITRO TECHNIQUES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SELF STIMULATION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STEREOISOMERISM; SUBSTANCE-RELATED DISORDERS;

EID: 84958107397     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.12.010     Document Type: Article

References (29)

1. Aarde S.M., Angrish D., Barlow D.J., Wright M.J., Vandewater S.A., Creehan K.M., Taffe M.A. Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addict. Biol. 2013, 18:786-799.
2. Balster R.L., Schuster C.R. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J. Exp. Anal. Behav. 1973, 20:119-129.
3. Bauer C.T., Banks M.L., Blough B.E., Negus S.S. Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br. J. Pharmacol. 2013, 168:850-862.
4. Baumann M.H., Ayestas M.A., Partilla J.S., Sink J.R., Shulgin A.T., Daley P.F., Cozzi N.V. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 2012, 37:1192-1203.
5. Baumann M.H., Partilla J.S., Lehner K.R., Thorndike E.B., Hoffman A.F., Holy M. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive "bath salts" products. Neuropsychopharmacology 2013, 38:552-562.
6. Blanckaert P., van Amsterdam J.G.C., Brunt T.M., Van den Berg J.D.J., Van Durme F., Maudens K., van Bussel J.C.H. 4-Methyl-amphetamine: a health threat for recreational amphetamine users. J. Psychopharmacol. 2013, 27:817-822.
7. Bonano J.S., Glennon R.A., De Felice L.J., Banks M.L., Negus S.S. Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Psychopharmacology 2014, 231:199-207.
8. Bonano J.S., Banks M.L., Kolanos R., Sakloth F., Barnier M.L., Glennon R.A., Cozzi N.V., Partilla J.S., Baumann M.H., Negus S.S. Abuse-related neurochemical and behavioral effects of para-substituted methcathinone analogs in rats. I. Quantitative structure-activity relationship (QSAR) analysis. Br. J. Pharmacol. 2015, 172:2433-2444.
9. Cozzi N.V., Brandt S.D., Daley P.F., Partilla J.S., Rothman R.B., Tulzer A., Baumann M.H. Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs. Euro J. Pharm. 2013, 699:180-187.
10. Creehan K.M., Vandewater S.A., Taffe M.A. Intravenous self-administration of mephedrone, methylone and MDMA in female rats. Neuropharmacology 2015, 92:90-97.
11. Glennon R.A., Young R., Hauck A.E., McKenney J.D. Structure-activity studies on amphetamine analogs using drug discrimination methodology. Pharm. Biochem. Behav. 1984, 21:895-901.
12. Glennon R.A., Yousif M., Naiman N., Kalix P. Methcathinone: a new and potent amphetamine-like agent. Pharm. Biochem. Behav. 1987, 26:547-551.
13. Gregg R.A., Baumann M.H., Partilla J.S., Bonano J.S., Vouga A., Tallarida C.S., Velvadapu V., Smith G.R., Peet M.M., Reitz A.B. Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats. Br. J. Pharmacol. 2015, 172:883-894.
14. Johanson C.E., Schuster C.R. A comparison of the behavioral effects of l-and dl-cathinone and d-amphetamine. J. Pharmacol. Exp. Ther. 1981, 219:355-362.
15. Kalix P. The releasing effect of the isomers of the alkaloid cathinone at central and peripheral catecholamine storage sites. Neuropharmacol 1986, 25:499-501.
16. Martínez-Clemente J., López-Arnau R., Carbó M., Pubill D., Camarasa J., Escubedo E. Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics. Psychopharmacology 2013, 229:295-306.
17. Motbey C.P., Clemens K.J., Apetz N., Winstock A.R., Ramsey J., Li K.M., McGregor I.S. High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine. J. Psychopharmacol. 2013, 27:823-836.
18. Musshoff F., Hottmann L., Hess C., Madea B. "Legal highs" from the German internet--"bath salt drugs" on the rise. Arch. Kriminol. 2012, 232:91-103.
19. Negus S.S., Miller L.L. Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol. Rev. 2014, 66:869-917.
20. Osorio-Olivares M., Rezende M.C., Sepulveda-Boza S., Cassels B.K., Baggio R.F., Munoz-Acevedo J.C. A two-step method for the preparation of homochiral cathinones. Tetrahedron Asymmetry 2003, 14:1473-1477.
21. Pedersen A.J., Reitzel L.A., Johansen S.S., Linnet K. In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug. Test. Anal. 2013, 5:430-438.
22. Robinson J.E., Agoglia A.E., Fish E.W., Krouse M.C., Malanga C.J. Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine. Behav. Brain Res. 2012, 234:76-81.
23. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 2001, 39:32-41.
24. Rothman R.B., Vu N., Partilla J.S., Roth B.L., Hufeisen S.J., Compton-Toth B.A., Glennon R.A. In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. J. Pharmacol. Exp. Ther. 2003, 307:138-145.
25. Sakloth F., Kolanos R., Mosier P.D., Bonano J.S., Banks M.L., Partilla J.S., Glennon R.A. Abuse-related neurochemical and behavioral effects of para-substituted methcathinone analogs in rats. II. Focus on steric parameters, molecular modeling, and a hydropathic interaction (HINT) analysis. Br. J. Pharm. 2014, 172:2210-2218.
26. Schindler C.W., Thorndike E.B., Goldberg S.R., Lehner K.R., Cozzi N.V., Brandt S.D., Baumann M.H. Reinforcing and neurochemical effects of the "bath salts" constituents 3, 4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 2015, [published online of print Aug 29].
27. Spiller H.A., Ryan M.L., Weston R.G., Jansen J. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin. Toxicol. 2011, 49(6):499-505.
28. Wee S., Anderson K.G., Baumann M.H., Rothman R.B., Blough B.E., Woolverton W.L. Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J. Pharmacol. Exp. Ther. 2005, 313:848-854.
29. Yanagita T. Intravenous self-administration of (-)-cathinone and 2-amino-1-(2,5-dimethoxy-4-methyl) phenylpropane in rhesus monkeys. Drug Alcohol Depend. 1986, 17:135-141.